InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Donenberg Phillip B., Director. Officer active across 1 companies, notably Taysha Gene Therapies, Inc.. In total, 2 disclosures have been published. Total volume traded: €41k. The latest transaction was filed on 2 February 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€20,7033,000 shares@ €6.90090.0012% mcap50.0% of flow
Common Stock
SEC:0001209191-22-006641:0·
Ideal exit: 30 Oct 2022 (T+270)
€20,7033,000 shares@ €6.90090.0012% mcap100.0% of flow
Common Stock
SEC:0001209191-22-006641·
Ideal exit: 30 Oct 2022 (T+270)
2 of 2 declarations
About Donenberg Phillip B.
Phillip B. Donenberg is a Board Member of Taysha Gene Therapies, Inc. In this role, he brings his expertise in corporate governance and financial strategy. Phillip is involved in overseeing operations and strategic decisions that influence the company's performance. His experience in the biopharmaceutical sector is a valuable asset to the board.
